AI Verdict
AMZN has stronger fundamentals based on our AI analysis.
ESPR vs AMZN Fundamental Comparison
| Metric | ESPR | AMZN |
|---|---|---|
| Revenue | $403.1M | $716.9B |
| Net Income | $-22.7M | $77.7B |
| Net Margin | -5.6% | 10.8% |
| ROE | N/A | 18.9% |
| ROA | -4.9% | 9.5% |
| Current Ratio | 1.54x | 1.05x |
| Debt/Equity | N/A | 0.17x |
| EPS | $-0.11 | $7.17 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ESPR vs AMZN: Frequently Asked Questions
Is ESPR or AMZN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AMZN has stronger fundamentals. ESPR is rated SELL (78% confidence) while AMZN is rated BUY (81% confidence). This is not investment advice.
How does ESPR compare to AMZN fundamentally?
Esperion Therapeutics, Inc. has ROE of N/A vs AMAZON COM INC's 18.9%. Net margins are -5.6% vs 10.8% respectively.
Which stock pays higher dividends, ESPR or AMZN?
ESPR has a dividend yield of N/A or no dividend while AMZN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ESPR or AMZN for long term?
For long-term investing, consider that ESPR has SELL rating with 78% confidence, while AMZN has BUY rating with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ESPR vs AMZN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ESPR vs AMZN, the AI consensus favors AMZN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.